Back to Screener

Healthcare

Charles River Laboratories International, Inc.(CRL)

Live Price

Offline

$212.71

+5.25% today

1Y Change

+33.32%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$9.15B
Revenue Growth
-0.9%
EPS Growth
-1555.0%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Charles River Laboratories International, Inc. (CRL) is a Healthcare stock with a market cap of $9.15B. The stock last traded around $212.71 and up 33.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -0.9%, EPS growth of -1555.0%, a dividend yield of 0.0%. What stands out right now is revenue -0.9%, EPS -1555.0%, free cash flow +3.4% with operating margin 10.7% and ROIC 7.1%. Valuation is more restrained than many high-expectation growth names at price/sales 2.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CRL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CRL vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CRL

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CRL Max Drawdown

-33.88%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CRL and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 6, 26
โ€”
Est 1.93
โ€”
โ€”
Est 979333.5B
โ€”
May 6
โ€”
Feb 18, 26
โœ“
2.39
Est 2.33
+2.6%
994227.0B
Est 987024.5B
+0.7%
Feb 18
โ€”
Nov 5, 25
โœ“
2.43
Est 2.32
+4.7%
1004852.0B
Est 987199.7B
+1.8%
Nov 5
โ€”
Aug 6, 25
โœ“
3.12
Est 2.50
+24.8%
1032135.0B
Est 968924.6B
+6.5%
Aug 6
โ€”
May 7, 25
โœ“
2.34
Est 2.06
+13.6%
984168.0B
Est 958789.9B
+2.6%
May 7
โ€”
Feb 19, 25
โœ“
2.66
Est 2.50
+6.4%
1002549.0B
Est 948220.9B
+5.7%
Feb 19
โ€”
Nov 6, 24
โœ“
2.59
Est 2.42
+7.0%
1009763.0B
Est 975989.5B
+3.5%
Nov 6
โ€”
Aug 7, 24
โœ“
2.80
Est 2.39
+17.1%
1026117.0B
Est 1024341.5B
+0.2%
Aug 7
โ€”
May 9, 24
โœ“
2.27
Est 2.06
+10.2%
1011560.0B
Est 992310.8B
+1.9%
May 9
โ€”
Feb 14, 24
โœ“
2.46
Est 2.39
+2.9%
1013476.0B
Est 991250.0B
+2.2%
Feb 14
โ€”
Nov 8, 23
โœ“
2.72
Est 2.35
+15.7%
1026623.0B
Est 1000500.0B
+2.6%
Nov 8
โ€”
Aug 9, 23
โœ“
2.69
Est 2.63
+2.3%
1059937.0B
Est 1053710.0B
+0.6%
Aug 9
โ€”
May 11, 23
โœ“
2.78
Est 2.59
+7.3%
1029373.0B
Est 986350.0B
+4.4%
May 11
โ€”
Feb 22, 23
โœ“
2.98
Est 2.75
+8.4%
1099843.0B
Est 1035027.8B
+6.3%
Feb 22
โ€”
Nov 2, 22
โœ“
2.63
Est 2.51
+4.8%
989157.0B
Est 970431.2B
+1.9%
Nov 2
โ€”
Aug 3, 22
โœ“
2.77
Est 2.73
+1.5%
973131.0B
Est 995181.3B
-2.2%
Aug 3
โ€”
May 4, 22
โœ“
2.75
Est 2.71
+1.5%
913929.0B
Est 910098.4B
+0.4%
May 4
โ€”
Feb 16, 22
โœ“
2.49
Est 2.43
+2.5%
905050.0B
Est 888266.8B
+1.9%
Feb 16
โ€”
Nov 3, 21
โœ“
2.70
Est 2.57
+5.1%
895937.0B
Est 850617.2B
+5.3%
Nov 3
โ€”
Aug 4, 21
โœ“
2.61
Est 2.39
+9.2%
914607.0B
Est 880440.0B
+3.9%
Aug 4
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener